Article Details
Retrieved on: 2022-10-01 14:31:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
About NasdaqGS:IMVT. Immunovant. Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of ...
Article found on: simplywall.st
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here